Form 4: Verrica Pharmaceuticals COO Buys Shares
Insider Transaction (Form 4)
David Zawitz, Chief Operating Officer of Verrica Pharmaceuticals Inc., purchased 6,000 shares of common stock on August 17, 2026 for $4.98 per share.
Summary
- Open-market purchase: acquired 6,000 Common Stock at $4.98 ($29,880) on August 17, 2026; holds 27,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $29,880, committing personal capital to the stock.
Insider Transactions
David Zawitz — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Open-market purchase | Common Stock | 6,000 | $5 | $29.9K | 27,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Open-market purchase (6,000 shares) |
Keywords
insider transaction, Form 4, VRCA, Verrica Pharmaceuticals Inc., bullish, David Zawitz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.